Long-Term Outcome of Bilateral Laparoscopic Adrenalectomy Measured by Disease-Specific Questionnaire in a Unique Group of Patients with Cushing's Syndrome
Overview
Authors
Affiliations
Background: Laparoscopic bilateral adrenalectomy (LBA) is recommended for patients with bilateral adrenal disease and occult or unresectable ectopic Cushing's syndrome (CS). There are limited data on long-term outcomes after LBA, partly due to the lack of disease-specific tools for the measurement of impact on patients' health and quality of life.
Methods: We used a disease-specific questionnaire covering all major clinicopathologic characteristics of CS. We compared the outcome from LBA to a control group of 60 patients who had thyroidectomy (matched for age, gender, and time of surgery, 2:1 control-to-CS).
Results: Twenty-eight patients (20 women and 8 men) underwent LBA for CS. Of them, 24 patients (86 %) provided responses to our questionnaire. Ninety-two percent of patients' responses indicated a significant improvement of general Cushing's physical features with complete resolution reported in 59 % of responses. Significant improvement of associated biochemical abnormalities and comorbidities was reported in 83 % of patients' responses including complete reversal in 58 %. Significant improvement in emotional-behavioral symptoms was reported in 84 % of patients' responses with complete recovery in 53 %. All patients expressed satisfaction with LBA and significant improvement in their general health and self-reported quality of life. All of the improvements after LBA were statistically significant compared with the control group.
Conclusions: Our disease-specific questionnaire enables a clearer understanding of the association between the clinical, metabolic, and emotional-behavioral features of CS, its treatment with LBA, and long-term impact on patient-reported quality of life. This disease-specific questionnaire may be useful for future studies in patients with CS.
Is Follow-up of Adrenal Incidentalomas Always Mandatory?.
Reimondo G, Muller A, Ingargiola E, Puglisi S, Terzolo M Endocrinol Metab (Seoul). 2020; 35(1):26-35.
PMID: 32207261 PMC: 7090287. DOI: 10.3803/EnM.2020.35.1.26.
Chiloiro S, Giampietro A, Raffaelli M, DAmato G, Bima C, Lauretti L Endocrine. 2019; 66(3):642-649.
PMID: 31583577 DOI: 10.1007/s12020-019-02091-9.
Babic B, de Roulet A, Volpe A, Nilubol N J Endocr Soc. 2019; 3(2):304-313.
PMID: 30652131 PMC: 6330172. DOI: 10.1210/js.2018-00278.
Knoble N, Nayroles G, Cheng C, Arnould B Orphanet J Rare Dis. 2018; 13(1):228.
PMID: 30567582 PMC: 6299940. DOI: 10.1186/s13023-018-0958-4.